News and Analysis
Innovation, Technology, and IP News
Major Med Device Product Developer GE HealthCare Collaborating with Healthcare Providers
Written by: Kregg Koch For good reasons, including product safety, quality assurance, development of delivery procedures and instructions, it has been a common practice for medical...
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Baxalta Inc. v. Genentech, Inc., Appeal No. 22-1461 (Fed. Cir. Sept. 20, 2023) Our Case of the Week focuses on the enablement requirement. It’s the first case...
Enter TitleFederal Circuit Revisits Standard for Enablement of Antibody Claims
Written by: Ashley C. Morales & Joseph Mallon, Ph.D. In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit affirmed the district court’s decision...
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories, Inc., Appeal Nos. 2021-2299, -2338 (Fed. Cir. Sept. 15, 2023) In a decade-old case that has ...
Prosecution History May Support a Motivation to Combine
Written by: Rhett D. Ramsey & Jacob R. Rosenbaum Elekta Limited v. Zap Surgical Systems, Inc. Before: Reyna, Stoll, and Stark. Appeal from the Patent Trial and Appeal Board. ...
Landmark CAFC Cases in Patent Law: Shaping the Future of Innovation
In the ever-evolving landscape of patent law, the Court of Appeals for the Federal Circuit (CAFC) has played a pivotal role in shaping the rules and precedents governing intellectual...
Feed tagged as "genetics":
IN RE: BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Before Prost, Lourie, and Reyna. Appeal from the Patent Trial and Appeal Board... Read More »
On September 25, 2020, Governor Gavin Newsom vetoed the California Genetic Information Privacy Act (“GIPA”), about which we reported here. Governor... Read More »
UPDATE: On September 25, 2020, Governor Gavin Newsom vetoed the California Genetic Information Privacy Act (“GIPA”). Click here for an... Read More »
The U.S. Food and Drug Administration (FDA) recently authorized 23andMe to market its Personal Genome Service Genetic Health Risk Report for BRCA1/BRCA2 (Selected... Read More »
On March 6, 2018, 23andMe, Inc. received the first-ever FDA authorization for a direct-to-consumer genetic test that analyzes gene mutations to help predict a... Read More »
Lung cancer is the most commonly occurring cancer worldwide, in terms of both incidence and mortality, with 1.61 million new cases in 2008 and 1.38 million... Read More »
A new test to diagnose celiac disease could be available in the near future. The disease causes gluten intolerance, leading to inflammation of the small intestine... Read More »
Just one decade ago, sequencing an entire human genome cost upwards of $10 million and took about three years to complete. Now, several companies are racing to... Read More »
Comments
Ann ConkleHard to believe that the price has fallen so far, so fast. It's very easy to envision the day when genome sequencing is part of routine health care.
May 29, 2012
Here’s your weekly roundup of exciting medical news.
Paralyzed people control robotic arms directly with brain activity
A new study in Nature... Read More »
A new study by Washington University researchers has discovered that not only can ovarian disease result from exposure to a wide range of environmental... Read More »
Scientists at Cambridge University and the Babraham Institute have demonstrated a new technique that could improve epigenetics research and help scientists better... Read More »
A gene that promotes initial development of the most common form of lung cancer and then drives its metastases has been identified by Mayo Clinic researchers in... Read More »
The “Domino,” developed by a University of Alberta research team, has the capability to perform the same genetic tests as most fully equipped laboratories ... Read More »
Researchers at Oak Ridge National Laboratory and Yale University have developed a new concept for use in a high-speed genomic sequencing device that may potentially... Read More »
A new study conducted by 15 institutions in three countries reveal that certain genetic abnormalities could lead to autism and other neurodevelopmental disorders... Read More »
Since President Richard Nixon declared a 'War on Cancer' with the signing of the National Cancer Act of 1971, the US has spent more than $100 billion on... Read More »
Comments
Anonymous a great illustration of the need for reform in the pharmaceutical industry: http://www.facebook.com/photo.php?v=10150635846921971
Apr 20, 2012
Caroline GreenCancer research indeed should be supported. Hope less people will suffer form cancers. http://www.creativebiomart.net/researcharea_Cancer.htm
Nov 27, 2015
Our understanding of genetic diseases has rapidly advanced. As processing of genetic codes becomes cheaper and easier, the market for individualized genetic testing... Read More »
Scientists have known for decades that genes are turned ‘on’ and ‘off’ by proteins known as transcription factors. They were thought to be... Read More »
A study published in the April 12 issue of Neuron has found that a newly-developed compound can reverse many of the symptoms associated with Fragile X syndrome (FXS). ... Read More »
Here are the top medical headlines of the week!
Gene sequencing may not actually be useful in determining health risks
Over the past several years the world... Read More »
